Krensavage Asset Management

Latest statistics and disclosures from Krensavage Asset Management's latest quarterly 13F-HR filing:

Portfolio Holdings for Krensavage Asset Management

Companies in the Krensavage Asset Management portfolio as of the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
United Therapeutics Corporation (UTHR) 16.46 539646 +17% 94.83
Regeneron Pharmaceuticals (REGN) 13.64 86817 -16% 488.29
Alexion Pharmaceuticals (ALXN) 13.35 462138 +47% 89.79
Enanta Pharmaceuticals 11.58 700318 +43% 51.43
Biogen Idec (BIIB) 11.27 110771 316.38
Taro Pharmaceutical Industries 9.59 487275 +43% 61.20
McKesson Corporation (MCK) 9.50 218306 -14% 135.26
Alkermes Plc 5.42 1.17M +29% 14.42
Gilead Sciences (GILD) 2.83 117755 -3% 74.76
RTI Biologics (RTIX) 2.22 4.03M +10% 1.71
Invacare Corporation (IVC) 2.12 887246 7.43
Anaptysbio Inc Common 2.02 443877 14.13
Change Healthcare Inc 0.01 3639 NEW 9.89

Past Filings by Krensavage Asset Management

View past SEC 13F filings by Krensavage Asset Management

View all filings